Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: A prospective study of couples in Rakai, Uganda

The Lancet Global Health

Volumn 3, Issue 8, 2015, Pages e478-e486

  Grabowski, Mary K ^a   Gray, Ronald H ^a,c   Makumbi, Fred ^c   Kagaayi, Joseph ^c   Redd, Andrew D ^d   Kigozi, Godfrey ^c   Reynolds, Steven J ^b,c,d   Nalugoda, Fred ^c   Lutalo, Tom ^c   Wawer, Maria J ^a,c   Serwadda, David ^c,e   Quinn, Thomas C ^b,d   Tobian, Aaron A R ^b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CIRCUMCISION; CLINICAL TRIAL (TOPIC); CONDOM USE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY PLANNING; FEMALE; HERPES SIMPLEX VIRUS 2; HORMONAL CONTRACEPTION; HUMAN; INCIDENCE; INFECTION RISK; MALE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEROCONVERSION; UNSAFE SEX; WESTERN BLOTTING; HERPES GENITALIS; IMMUNOLOGY; INJECTION; ISOLATION AND PURIFICATION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEXUALITY; TRANSMISSION; UGANDA; VIROLOGY; YOUNG ADULT;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INCIDENCE; INJECTIONS; MALE; MEDROXYPROGESTERONE ACETATE; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEROCONVERSION; SEXUAL PARTNERS; UGANDA; YOUNG ADULT;

EID: 84944232820     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)00086-8     Document Type: Article

References (54)

1. Darroch JE, Singh S Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet 2013, 381:1756-1762.
2. Trussel J Contraceptive failure in the United States. Contraception 2011, 83:397-404.
3. Jacobstein R, Polis CB Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynaecol 2014, 28:795-806.
4. Polis CB, Phillips SJ, Curtis KM, et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception 2014, 90:360-390.
5. Cates W Research on hormonal contraception and HIV. Lancet 2014, 383:303-304. for the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Consortium.
6. Polis CB, Westreich D, Balkus JE, Heffron R Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS 2013, 27(suppl 1):S35-S43. for the Participants of the 2013 HC-HIV Observational Analysis Meeting.
7. Wand H, Ramjee G The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012, 26:375-380.
8. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007, 21:1771-1777.
9. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010, 24:1778-1781.
10. Morrison CS, Skoler-Karpoff S, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2012, 26:497-504.
11. McCoy SI, Zheng W, Montgomery ET, et al. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS 2013, 27:1001-1009.
12. Myer L, Denny L, Wright TC, Kuhn L Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007, 36:166-174.
13. Kleinschmidt I, Rees H, Delany S, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007, 75:461-467.
14. Ralph LJ, McCoy SI, Shiu K, Padian NS Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis 2015, 15:181-189.
15. Blish CA, Baeten JM Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol 2011, 65:302-307.
16. Hel Z, Stringer E, Mestecky J Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev 2010, 31:79-97.
17. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996, 2:1084-1089.
18. Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retroviruses 1998, 14(suppl 1):S125-S130.
19. Kuhn L, Denny L, Pollack AE, Wright TC Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception 1999, 59:363-367.
20. Smith SM, Mefford M, Sodora D, et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004, 18:1637-1643.
21. Mauck CK, Callahan MM, Baker J, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999, 60:15-24.
22. Sheffield JS, Wendel GD, McIntire DD, Norgard MV The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci 2009, 16:20-31.
23. Wieser F, Hosmann J, Tschugguel W, Czerwenka K, Sedivy R, Huber JC Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril 2001, 75:1234-1235.
24. Prakash M, Kapembwa MS, Gotch F, Patterson S Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002, 54(1-2):117-131.
25. Gupta R, Warren T, Wald A Genital herpes. Lancet 2007, 370:2127-2137.
26. Tobian AA, Quinn TC Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr Opin HIV AIDS 2009, 4:294-299.
27. Schiffer JT, Corey L Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nat Med 2013, 19:280-290.
28. Brankin AE, Tobian AA, Laeyendecker O, et al. Aetiology of genital ulcer disease in female partners of male participants in a circumcision trial in Uganda. Int J STD AIDS 2009, 20:650-651.
29. Suntoke TR, Hardick A, Tobian AA, et al. Evaluation of multiplex real-time PCR for detection of H. ducreyi, T. pallidum, HSV-1, and HSV-2 in the diagnosis of genital ulcer disease in Rakai District, Uganda. Sex Transm Infect 2009, 85:97-101.
30. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73-83.
31. Corey L Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues. J Infect Dis 2007, 195:1242-1244.
32. Peretti S, Shaw A, Blanchard J, et al. Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses. Blood 2005, 106:1305-1313.
33. de Jong MA, de Witte L, Bolmstedt A, van Kooyk Y, Geijtenbeek TB Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J Gen Virol 2008, 89:2398-2409.
34. Mikloska Z, Bosnjak L, Cunningham AL Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol 2001, 75:5958-5964.
35. Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol 2003, 77:9845-9851.
36. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003, 77:4558-4565.
37. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infections among men in Rakai, Uganda. J Infect Dis 2009, 199:945-949.
38. Chohan V, Baeten JM, Benki S, et al. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya. Sex Transm Infect 2009, 85:489-492.
39. Tobian AA, Serwadda D, Quinn TC Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009, 360:1298-1309.
40. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369:657-666.
41. Wawer MJ, Tobian AA, Kigozi G, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet 2011, 377:209-218.
42. Tobian AA, Kigozi G, Redd AD, et al. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis 2012, 205:486-490.
43. Tobian AA, Ssempijja V, Kigozi G, et al. Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS 2009, 23:1589-1594.
44. Gamiel JL, Tobian AA, Laeyendecker OB, et al. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol 2008, 15:888-890.
45. Allison PD Discrete time methods for the analysis of event histories. Sociol Methodol 1982, 13:61-98.
46. Liang KY, Zeger S Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
47. Pan W Akaike's information criterion in generalized estimating equations. Biometrics 2001, 57:120-125.
48. Drake AL, Wagner A, Richardson B, John-Stewart G Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med 2014, 11:e1001608.
49. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005, 366:1182-1188.
50. Kiddugavu M, Makumbi F, Wawer MJ, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003, 17:233-240.
51. Lutalo T, Musoke R, Kong X, et al. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS 2013, 27(suppl 1):S27-S34.
52. Weller S, Davis K Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002, 1. CD003255.
53. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009, 169:1233-1240.
54. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012, 12:19-26.